Novonesis shares shine on Q2 beat, outlook hike, share buyback

Novozymes A/S

20/08/2026 08:14

** Shares in Novonesis NSISb.CO rise 8% after the Danish biosolutions maker reported Q2 results above estimates, raised FY guidance and announced a share buyback
** Its Q2 adjusted EBITDA came in at €419.2 million ($489.5 million), above the company-provided consensus of €412.8 million
** The quarterly organic growth was 9%, above estimate of 7.4%
** The company announced a share buyback of €1 billion starting in H2
** Novonesis also expects FY organic sales growth of 7-8%, up from previous 5-7% and expects FY adjusted EBITDA in the higher end of the 37-38% range
** Jyske Bank analyst Haider Anjum and J.P.Morgan note the broad-based growth across almost all divisions
** "This underlines an increasingly strong competitive position" with the company expanding its core business and gaining market share in existing markets, Anjum says
** The share buyback sends an "important" signal of confidence in cash flow and balance sheet, he says
** The buyback should be well-received despite its longer completion time, JPM says
** Shares were up at the top of the STOXX 600 index .STOXX at 0715 GMT, on track for best day since October 2015 if gains hold
     
     
($1 = 0.8565 euros)

(Reporting by Vera Dvorakova)
((vera.dvorakova@thomsonreuters.com))